Directory
>
Helene Petitjean
Helene Petitjean
General Practitioner | Bristol Myers Squibb
New Jersey, Princeton, United States
Helene Petitjean
Summary
Helene Petitjean is an accomplished Executive Director specializing in cardiovascular drug development and clinical evaluations. With over 20 years of experience at leading pharmaceutical companies including Bristol Myers Squibb, Novo Nordisk, Daiichi Sankyo, and Novartis, she has a proven track record in managing complex clinical trials and leading successful M&A transactions. Helene has been instrumental in the development of several high-profile drugs, contributing to multi-billion-dollar deals and numerous clinical trials. Her leadership experience spans across various therapeutic areas, particularly in cardiovascular and metabolic health. Fluent in both English and French, she combines her medical expertise with strategic insight to drive innovation and collaboration in drug development. In addition to her corporate roles, she serves as a Director and Board Member for the French-American Piano Society, reflecting her diverse interests beyond the pharmaceutical industry. Helene's commitment to excellence and her ability to navigate the complexities of drug development make her a key player in her field.
Helene Petitjean
Work Experience
Executive Director, Cardiovascular, Head of Clinical Evaluations and Collaborations at
Bristol Myers Squibb
October 2021 - Present
Helene Petitjean
Education
Pierre and Marie Curie University, MD, Medical School
January 1988
Frequently Asked Questions about Helene Petitjean
What is Helene Petitjean email address?
Helene Petitjean's primary email address is ****************@bms.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Helene Petitjean work for?
Helene Petitjean is a General Practitioner at Bristol Myers Squibb.
Where Helene Petitjean graduated from?
Helene Petitjean holds a degree in null from Pierre and Marie Curie University.
How can I directly contact Helene Petitjean?
To contact Helene Petitjean directly, you can use the email address ****************@bms.com. Complete contact information is available upon registration with Muraena.
Who is Helene Petitjean?
Helene Petitjean is an accomplished Executive Director specializing in cardiovascular drug development and clinical evaluations. With over 20 years of experience at leading pharmaceutical companies including Bristol Myers Squibb, Novo Nordisk, Daiichi Sankyo, and Novartis, she has a proven track record in managing complex clinical trials and leading successful M&A transactions. Helene has been instrumental in the development of several high-profile drugs, contributing to multi-billion-dollar deals and numerous clinical trials. Her leadership experience spans across various therapeutic areas, particularly in cardiovascular and metabolic health. Fluent in both English and French, she combines her medical expertise with strategic insight to drive innovation and collaboration in drug development. In addition to her corporate roles, she serves as a Director and Board Member for the French-American Piano Society, reflecting her diverse interests beyond the pharmaceutical industry. Helene's commitment to excellence and her ability to navigate the complexities of drug development make her a key player in her field.
Helene`s contact details
****************@bms.com
***@novonordisk.com
Colleagues
QC Lab Technician
Scientist, Operations
Junior Research Fellow
stagiair
Vice President Corporate Development, Head of M&A
Senior Audit Associate
Postdoctoral Fellow
Attorney
Laboratory Technician
Executive Director, Head of Regulatory Information and Submission Management